HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CVS/Albertsons deal

This article was originally published in The Tan Sheet

Executive Summary

The Hart-Scott-Rodino waiting period for CVS's acquisition of some 700 stand-alone Sav-on and Osco Drugstores has expired without a request for additional information by FTC, CVS announces March 14. "No divestiture of retail stores or other assets was required and the FTC imposed no conditions or restrictions on the transaction," Albertsons states in a same-day release. The acquisition will provide CVS with "an immediate critical mass of stores" in Southern California, CEO Tom Ryan noted (1"The Tan Sheet" Jan. 30, 2006, p. 12)...

The Hart-Scott-Rodino waiting period for CVS's acquisition of some 700 stand-alone Sav-on and Osco Drugstores has expired without a request for additional information by FTC, CVS announces March 14. "No divestiture of retail stores or other assets was required and the FTC imposed no conditions or restrictions on the transaction," Albertsons states in a same-day release. The acquisition will provide CVS with "an immediate critical mass of stores" in Southern California, CEO Tom Ryan noted (1 (Also see "CVS Buy Of 700 Albertsons Stores Reinforces Frontrunner Position" - Pink Sheet, 30 Jan, 2006.), p. 12)....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125858

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel